Few research compounds have an origin story like DSIP. In 1977, Swiss researchers passing dialyzed blood between rabbits found that blood from sleeping animals carried something that altered brain activity in awake ones. The isolated factor — nine amino acids — was named delta sleep-inducing peptide.
An Unfinished Puzzle
Nearly five decades later, DSIP retains a rare status: documented effects across multiple preclinical models, but no definitively identified receptor. That open question is part of what keeps it in research catalogs — it represents genuinely unfinished neurobiology.
What Studies Examine
The literature clusters around delta-wave sleep architecture in EEG studies, interactions with the stress axis including cortisol-related endpoints, and broader neuroendocrine modulation. Its unusual profile also makes it a candidate in studies of circadian disruption models.
Research Context
DSIP sits in our General Health/Wellness collection alongside other neuroendocrine research compounds like Oxytocin — each batch third-party verified with COA documentation.
All products discussed are intended strictly for in-vitro research and laboratory use only. They are not for human or veterinary use, consumption, or therapeutic application.
